Trading Signals: EBS Stock Price Prediction and Forecast (Wed. Nov. 15, 2006 - Fri. May. 26, 2023)(Emergent BioSolutions Inc.)
| EBS latest price $26.4700 (-2.68%) ($26.2800 - $27.3800) on Fri. Jan. 30, 2015. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 1.92% (three month average) | | RSI | 56 | | Latest Price | $26.4700(-2.68%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | EBS declines -0.3% a day on average for past five trading days. | | Weekly Trend | EBS advances 1.3% a week on average for past two weeks. | | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support EBS advance at 0% a week (0% probability)
IBB(48%) XBI(45%) IWM(44%) SPY(42%) QQQ(41%) | | Factors Impacting EBS price | EBS will decline at least -0.96% in a week (0% probabilities).
VIXM(-11%) TLT(-10%) SHY(-6%) IGOV(-3%) UUP(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -0.96% (StdDev 1.92%) | | Hourly BBV | 0 () | | Intraday Trend | -2.1% | | | | | |
|
| 5 Day Moving Average | $27(-1.96%) | | 10 Day Moving Average | $26.86(-1.45%) | | 20 Day Moving Average | $26.36(0.42%) | | To recent high | -3% | | To recent low | 25.9% | | Market Cap | $1.4b | | | | | | |
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD. |